S100 proteins in cancer

Anne R. Bresnick, David J. Weber, Danna B. Zimmer

Research output: Contribution to journalArticle

221 Citations (Scopus)

Abstract

In humans, the S100 protein family is composed of 21 members that exhibit a high degree of structural similarity, but are not functionally interchangeable. This family of proteins modulates cellular responses by functioning both as intracellular Ca 2+ sensors and as extracellular factors. Dysregulated expression of multiple members of the S100 family is a common feature of human cancers, with each type of cancer showing a unique S100 protein profile or signature. Emerging in vivo evidence indicates that the biology of most S100 proteins is complex and multifactorial, and that these proteins actively contribute to tumorigenic processes such as cell proliferation, metastasis, angiogenesis and immune evasion. Drug discovery efforts have identified leads for inhibiting several S100 family members, and two of the identified inhibitors have progressed to clinical trials in patients with cancer. This Review highlights new findings regarding the role of S100 family members in cancer diagnosis and treatment, the contribution of S100 signalling to tumour biology, and the discovery and development of S100 inhibitors for treating cancer.

Original languageEnglish (US)
Pages (from-to)96-109
Number of pages14
JournalNature Reviews Cancer
Volume15
Issue number2
DOIs
StatePublished - Jan 23 2015

Fingerprint

S100 Proteins
Neoplasms
Immune Evasion
Drug Discovery
Proteins
Cell Proliferation
Clinical Trials
Neoplasm Metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

S100 proteins in cancer. / Bresnick, Anne R.; Weber, David J.; Zimmer, Danna B.

In: Nature Reviews Cancer, Vol. 15, No. 2, 23.01.2015, p. 96-109.

Research output: Contribution to journalArticle

Bresnick, AR, Weber, DJ & Zimmer, DB 2015, 'S100 proteins in cancer', Nature Reviews Cancer, vol. 15, no. 2, pp. 96-109. https://doi.org/10.1038/nrc3893
Bresnick, Anne R. ; Weber, David J. ; Zimmer, Danna B. / S100 proteins in cancer. In: Nature Reviews Cancer. 2015 ; Vol. 15, No. 2. pp. 96-109.
@article{7964d21a7c6149da8dd06e4eaba17108,
title = "S100 proteins in cancer",
abstract = "In humans, the S100 protein family is composed of 21 members that exhibit a high degree of structural similarity, but are not functionally interchangeable. This family of proteins modulates cellular responses by functioning both as intracellular Ca 2+ sensors and as extracellular factors. Dysregulated expression of multiple members of the S100 family is a common feature of human cancers, with each type of cancer showing a unique S100 protein profile or signature. Emerging in vivo evidence indicates that the biology of most S100 proteins is complex and multifactorial, and that these proteins actively contribute to tumorigenic processes such as cell proliferation, metastasis, angiogenesis and immune evasion. Drug discovery efforts have identified leads for inhibiting several S100 family members, and two of the identified inhibitors have progressed to clinical trials in patients with cancer. This Review highlights new findings regarding the role of S100 family members in cancer diagnosis and treatment, the contribution of S100 signalling to tumour biology, and the discovery and development of S100 inhibitors for treating cancer.",
author = "Bresnick, {Anne R.} and Weber, {David J.} and Zimmer, {Danna B.}",
year = "2015",
month = "1",
day = "23",
doi = "10.1038/nrc3893",
language = "English (US)",
volume = "15",
pages = "96--109",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - S100 proteins in cancer

AU - Bresnick, Anne R.

AU - Weber, David J.

AU - Zimmer, Danna B.

PY - 2015/1/23

Y1 - 2015/1/23

N2 - In humans, the S100 protein family is composed of 21 members that exhibit a high degree of structural similarity, but are not functionally interchangeable. This family of proteins modulates cellular responses by functioning both as intracellular Ca 2+ sensors and as extracellular factors. Dysregulated expression of multiple members of the S100 family is a common feature of human cancers, with each type of cancer showing a unique S100 protein profile or signature. Emerging in vivo evidence indicates that the biology of most S100 proteins is complex and multifactorial, and that these proteins actively contribute to tumorigenic processes such as cell proliferation, metastasis, angiogenesis and immune evasion. Drug discovery efforts have identified leads for inhibiting several S100 family members, and two of the identified inhibitors have progressed to clinical trials in patients with cancer. This Review highlights new findings regarding the role of S100 family members in cancer diagnosis and treatment, the contribution of S100 signalling to tumour biology, and the discovery and development of S100 inhibitors for treating cancer.

AB - In humans, the S100 protein family is composed of 21 members that exhibit a high degree of structural similarity, but are not functionally interchangeable. This family of proteins modulates cellular responses by functioning both as intracellular Ca 2+ sensors and as extracellular factors. Dysregulated expression of multiple members of the S100 family is a common feature of human cancers, with each type of cancer showing a unique S100 protein profile or signature. Emerging in vivo evidence indicates that the biology of most S100 proteins is complex and multifactorial, and that these proteins actively contribute to tumorigenic processes such as cell proliferation, metastasis, angiogenesis and immune evasion. Drug discovery efforts have identified leads for inhibiting several S100 family members, and two of the identified inhibitors have progressed to clinical trials in patients with cancer. This Review highlights new findings regarding the role of S100 family members in cancer diagnosis and treatment, the contribution of S100 signalling to tumour biology, and the discovery and development of S100 inhibitors for treating cancer.

UR - http://www.scopus.com/inward/record.url?scp=84923082160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923082160&partnerID=8YFLogxK

U2 - 10.1038/nrc3893

DO - 10.1038/nrc3893

M3 - Article

VL - 15

SP - 96

EP - 109

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 2

ER -